Acasti Pharma (CVE:ACST) Stock Price Up 1.8% – Here’s What Happened

by · The Markets Daily

Acasti Pharma Inc. (CVE:ACST – Get Free Report) traded up 1.8% during trading on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. 2,450 shares were traded during mid-day trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.

Acasti Pharma Price Performance

The stock has a market cap of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The company has a 50 day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58. The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52.

Acasti Pharma Company Profile

(Get Free Report)

Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

Featured Stories